Sacubitril / Valsartan

Abbreviation
ARNI
Disease(s)
Cardiovascular Diseases
Background
.pdf
Patent oppositions filed in
India

Valsartan belongs angiotensin II receptor blocker [ARB] family of drugs and Sacubitril is a neprilysn (NEP) inhibitor prodrug having natriuretic activity. It is a fixed dose combination medicine used for the treatment of heart failure.

This drug is missing the following documents, can you help us by contributing something?

Patent Information

Information of patent applications filed at local or international levels, that are contributed by the users of PODB as being relevant to this medicine

Please note that PODB does not provide and guarantee the comprehensive patent landscape in all countries.

*For more knowledge of patent search, please refer to the tutorial Step 2: Patent Search & Analysis
*For more information of the patent landscape on medicines, please also refer to WHO patent landscape reports, UNITAID patent landscape reports, Medicines Patent Pool Patent Status Database

Patent Applications

The table includes information of patent applications as filed in different countries, that are contributed by PODB users as being seen as relevant to this medicine.

CountryFiling datePriority dateApplicantNational numberInternational numberStatusPatent typeMore info
India08-07-2007Novartis AG4412/DELNP/2007 (IN414518)WO/2007/056546GrantedCompositionsView/Comment
India09-07-2004Novartis AG1538/CHENP/2004 (IN229051)WO/2003/059345A1GrantedCompositionsView/Comment
India02-02-2017Novartis AG201714003906 (IN378324)WO/2017/134597GrantedCompositionsView/Comment
India09-12-2016Novartis AG201614042178 (IN352185)WO/2017/098430GrantedProcessesView/Comment
India05-02-2009Novartis AG873/DELNP/2009 (IN268938)WO/2008/031567GrantedProcessesView/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top

Oppositions

Information related to relevant oppositions from around the world.

Patent Oppositions

The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.

Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.

CountryDateWho FiledOpposition typeOpposition statusPatent typeRelated patent applicationMore info
India06-09-2016Natco Pharma LtdPre-GrantRefusedCompositions4412/DELNP/2007View/Comment
India23-08-2017Kumar SushobhanPre-GrantRefusedCompositions4412/DELNP/2007View/Comment
India02-09-2022Ketakee S DurvePre-GrantRefusedCompositions4412/DELNP/2007View/Comment
India04-11-2022Dr.Kanchan KohliPre-GrantRefusedCompositions4412/DELNP/2007View/Comment
India03-11-2022Hemavathi RPre-GrantRefusedCompositions4412/DELNP/2007View/Comment
India13-06-2019Dr. Reddy Laboratories LimitedPre-GrantRefusedCompositions4412/DELNP/2007View/Comment
India25-05-2016Indian Pharmaceutical AlliancePre-GrantRefusedCompositions4412/DELNP/2007View/Comment
India18-09-2020Srinivasa RaoPre-GrantRefusedCompositions4412/DELNP/2007View/Comment
India20-05-2022Charanjit Kumar SehgalPre-GrantRefusedCompositions4412/DELNP/2007View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top